Kairos Pharma, LTD. (KAPA) — DEF 14A Filings
All DEF 14A filings from Kairos Pharma, LTD.. Browse 1 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (1)
-
Kairos Pharma Files 2025 Proxy Statement
— May 1, 2025 Risk: low
Kairos Pharma, LTD. filed its definitive proxy statement (DEF 14A) on May 1, 2025, for the fiscal year ending December 31, 2024. The company, incorporated in De
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX